Patents
Patents for C07C 239 - Compounds containing nitrogen-to-halogen bonds; Hydroxylamino compounds or ethers or esters thereof (5,130)
02/2002
02/19/2002US6348629 Inhibitor comprising free radical quenching agent having hydrophilic tail, which quenches free radical polymerization in aqueous phase and remains substantially in aqueous phase throughout polymerization
02/19/2002CA2147590C A process for producing substituted amines and a method for purifying synthetic intermediates therefor
02/14/2002WO2002012149A2 Method for preparing alkoxyamines from nitroxides
02/14/2002US20020019539 Antiarthritc agents; anticancer agent
02/13/2002EP1178955A1 Polyalcoxyamines obtained from beta-substituted nitroxides
02/13/2002EP0977728B1 Process for the preparation of high purity o-substituted hydroxylamine derivatives
02/12/2002US6346242 Compounds and compositions for delivering active agents
02/07/2002WO2002010226A1 Acrylate contact adhesive materials having tight molecular weight distribution
02/07/2002US20020016320 Inhibiting beta-secretase enzyme activity and A beta peptide production.
02/07/2002DE10036801A1 Acrylathaftklebemassen mit enger Molekulargewichtsverteilung Acrylic PSAs with a narrow molecular weight distribution
02/06/2002EP1177308A2 Process for producing nitrosoniom ions from a nitroxyl compound, their application in the selective oxidation of primary alcohols, and novel carbohydrate aldehydes
01/2002
01/31/2002US20020013494 Surfactants
01/24/2002US20020007585 Transition-metal-catalyzed process for the preparation of sterically hindered N-substituted aryloxyamines
01/23/2002EP1173409A1 Process for producing nitrosonium ions
01/10/2002WO2002002520A2 Compounds to treat alzheimer's disease
01/10/2002WO2002002518A2 Compounds to treat alzheimer's disease
01/10/2002WO2002002512A2 Compounds to treat alzheimer's disease
01/10/2002WO2002002506A2 Compounds to treat alzheimer's disease
01/10/2002WO2002002505A2 Compounds to treat alzheimer's disease
01/10/2002CA2410972A1 Compounds to treat alzheimer's disease
01/10/2002CA2410680A1 Compounds to treat alzheimer's disease
01/10/2002CA2410651A1 Compounds to treat alzheimer's disease
01/09/2002EP1169031A1 Antimicrobial agents
01/08/2002CA2040904C Alkenyl substituted stabilizers
01/02/2002EP1165495A1 Resorcinol derivatives
12/2001
12/19/2001CN1327383A Pharmaceutical for treatment of neurological and neuropsychiatric disorders
12/18/2001US6331564 Use of triaryl methane compounds for inhibiting unwanted cellular proliferation associated with inflammatory disease
12/12/2001EP1161413A1 Method for the continuous production of methoxyamine hydrochloride
12/11/2001US6329405 As ileal bile acid transporter inhibitor, for therapy of hyperlipemia
12/11/2001US6329061 Multilayer; containing metal particles
12/06/2001WO2001092218A2 Polyamine analogues as therapeutic and diagnostic agents
12/06/2001CA2410935A1 Novel polyamine analogues as therapeutic and diagnostic agents
12/05/2001CN1075807C Iminooxymethylene anilides, process and intermediate products for preparing the same and pesticides containing the same
12/04/2001US6325876 Energetic plasticizers containing 3,3-bis(difluoroamino)-1,5-dinitratopentane and method of preparation
11/2001
11/29/2001WO2001090113A1 Hydroxylamine esters as polymerization initiators
11/28/2001CN1324338A Methods and compositions for inhibiting polymerization of ethylenically unsaturated hydrocarbons
11/27/2001CA2041835C Cyclohexenone oxime ethers, their preparation and their use as herbicides
11/22/2001WO2001087822A1 Novel phenyl-propargylether derivatives
11/21/2001EP1154987A1 Phenylalaninol derivatives
11/13/2001US6315848 Laminated glass with functional ultra-fine particles and method of producing same
11/08/2001WO2001083455A1 Process for the preparation of sterically hindered aryloxyamines
11/08/2001WO2000050621A3 Process for producing nitrosoniom ions from a nitroxyl compound, their application in the selective oxidation of primary alcohols, and novel carbohydrate aldehydes
11/08/2001US20010039315 For addition polymerization; forming a polymer with alkoxyamine end groups that can be used in a two-stage process for making block polymers; narrow polydispersity and high monomer to polymer conversion ratio
11/08/2001CA2407195A1 Process for the preparation of sterically hindered aryloxyamines
11/07/2001EP0871609B1 Cyclohexenone oxime ether metal salts
11/06/2001US6313305 Cephalosporins
11/06/2001US6313302 Opioid kappa receptor antagonists; side effect reduction; analgesics, antiinflammatory agents, anesthetics, and neuroprotectants
10/2001
10/30/2001US6310095 Inhibitors of protein isoprenyl transferases
10/30/2001US6310061 Pyrrolidinyl and pyrrolinyl ethylamine compounds as kappa agonists
10/24/2001CN1073553C Process for producing N-arylhydroxylamines and N-hetarylhydroxylamines
10/23/2001US6307094 Process for substituted 3-hydroxybutyrate esters
10/23/2001US6307061 Pyrrolidinyl and pyrrolinyl ethylamine compounds as kappa agonists
10/18/2001US20010031896 By reacting with 2,2,2-trifluoroethylformate in an optionally buffered solvent; by-product inhibition
10/16/2001US6303602 Useful as analgesic, anesthetic, anti-inflammatory or neuroprotective agent, or for therapy of arthritis, stroke of functional bowel disease
10/11/2001WO2001074757A1 Process for the selective n-formylation of n-hydroxylamines
10/11/2001CA2403529A1 Process for the selective n-formylation of n-hydroxylamines
10/09/2001US6300513 Causing n-oxyl compound, n-hydroxy-2,2,6,6-tetramethylpiperidine compound and 2,2,6,6-tetramethylpiperidine compound to co-exist in vinyl compound
10/02/2001CA2250092C Triaryl and diaryl compounds, their analogues and uses thereof
10/02/2001CA2093609C Color development composition and method of processing silver halide colour photographic material using the same
09/2001
09/25/2001US6294569 Analgesic at central nervous system in the mammalian subject. also, these compounds are inflammatory pain caused, for example by burns (induced by a contact with heat, acid or the other rheumatism or the like, in the said subject.
09/25/2001US6294557 Analgesic at central nervous system in the mammalian subject. also, these compounds are inflammatory pain caused, for example by burns (induced by a contact with heat, acid or the other rheumatism or the like, in the said subject.
09/20/2001US20010023240 Compounds and compositions for delivering active agents
09/06/2001US20010020024 Opioid analgesics
09/04/2001US6284914 Highly water-soluble metalloproteinase inhibitors
08/2001
08/29/2001EP1127040A1 Methods and compositions for inhibiting polymerization of ethylenically unsaturated hydrocarbons
08/28/2001CA2017252C Retroviral protease inhibiting compounds
08/23/2001WO2001060785A1 Acetal hydroxylamine compounds
08/23/2001US20010016261 Multilayer; containing metal particles
08/22/2001EP1037873B1 Method for producing organic hydroxylamines
08/22/2001CN1309632A Salts of N-tert-butylhydroxylamine
08/16/2001US20010014683 Analgesics; side effect reduction
08/08/2001CN1307553A Process for solid phase synthesis of aldehyde ketone oxime, amine, hydroxamic acid and alpha, beta-unsaturated carboxylic acid and aldehyde compounds
08/07/2001US6271357 Oligonucleotide mimics having nitrogen-containing linkages
08/02/2001US20010011091 Pyrrolidinyl and pyrrolinyl ethylamine compounds as kappa agonists
07/2001
07/26/2001US20010009968 Methods and compositions for inhibiting polymerization of ethylenically unsaturated hydrocarbons
07/26/2001US20010009921 Pyrrolidinyl and pyrrolinyl ethylamine compounds as kappa agonists
07/19/2001WO2001002345A3 Mono and multifunctional alkoxyamines for the preparation of functionalized macromers
07/19/2001US20010008928 Free radical catalyst
07/19/2001US20010008890 Pyrrolidinyl and pyrrolinyl ethylamine compounds as kappa agonists
07/18/2001EP1116711A2 2-aminoalkyl-1,4-diaminobenzene derivatives and dye composition containing these compounds
07/18/2001EP1115695A1 (r)-chiral halogenated 1-substitutedamino-(n+1)-alkanols useful for inhibiting cholesteryl ester transfer protein activity
07/18/2001EP1115693A1 SUBSTITUTED POLYCYCLIC ARYL AND HETEROARYL $i(TERTIARY)-HETEROALKYLAMINES USEFUL FOR INHIBITING CHOLESTERYL ESTER TRANSFER PROTEIN ACTIVITY
07/17/2001US6262206 Polymerizable compositions containing alkoxyamine compounds derived from nitroso- or nitrone compounds
07/11/2001EP1114813A2 Method of stabilizing N-oxyl compounds in vinyl compounds
07/11/2001CN1068381C Method of producing taxane-type diterpene
07/04/2001CN1301690A Method for stabilizing N-oxyl compound in vinyl compound
07/03/2001US6255489 Method for producing (hetero)aromatic hydroxylamines
06/2001
06/28/2001WO2001046124A1 Aromatic diamide derivatives, chemicals for agricultural or horticultural use and usage thereof
06/28/2001WO2000078710A8 Method of making hydroxylamine salts
06/28/2001US20010005755 Method of stabilizing N-oxyl compounds in vinyl compounds
06/26/2001US6252083 Fungicides, insecticides, nematocides
06/26/2001US6251574 Color photographic developer concentrate
06/21/2001WO2001044154A1 Dihalopropenyloxybenzene derivatives and pesticides containing the same as the active ingredient
06/19/2001CA1341257C Benzhydrylamine derivatives
06/14/2001WO2001042179A1 Compounds which mimic the chemical and biological properties of discodermolide
06/14/2001CA2393968A1 Compounds which mimic the chemical and biological properties of discodermolide
06/13/2001EP1105383A2 Synthetic techniques and intermediates for polyhydroxy, dienyl lactone derivatives
06/05/2001US6242616 Synthetic techniques and intermediates for polyhydroxy, dienyl lactone derivatives
06/05/2001US6242433 Geranylgeranyl-derivatives, process for the preparation thereof and related pharmaceutical compositions
05/2001
05/23/2001EP1100772A1 Open chain alkoxyamine compounds and their use as polymerization regulators
1 ... 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 ... 52